Skip to main content

Table 3 Measurement domains, survey methods and collection time-points

From: Establishing and evaluating physician-pharmacist collaborative clinics to manage patients with type 2 diabetes in primary hospitals in Hunan province: study protocol of a multi-site randomized controlled trial in the era of COVID-19 pandemic

Variable

Component

Measurement methods

Baseline

3rd M

6th M

9th M

12th M

Socio-demographic parameters

Gender, age, telephone, address, education, occupation and annual income

Face-to-face interview

√

    

Clinical parameters

Height, weight, waist to hip ratio, fasting blood glucose, 2-h postprandial blood glucose, HbA1c, diabetes complications, blood pressure and lipid files

Face-to-face interview, telephone or online interview

√

√

√

√

√

Behavior parameters

Medication adherence, diabetes’ knowledge, lifestyle, diabetes treatment target and treatment behavior

 

√

√

√

√

√

√

√

Treatment satisfaction

     

√

Economic parameters

Direct costs (Average daily Medicine, outpatient clinic visit fees, and hospitalization fees if occurs), Indirect costs (deducted income due to absence of working, traffic and accommodation fees)

Face-to-face interview, telephone or online interview

√

√

√

√

√